FDA Approved: INFASURF — Supplemental Application (ONY Biotech Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INFASURF (calfactant) submitted by ONY Biotech Inc., approving labeling changes and/or expanded indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Drugs mentioned

• INFASURF (calfactant)

Snippet

SUPPL AP for INFASURF (CALFACTANT)